Rafael Segal

Medicine & Life Sciences

1. (T,G)-A-L 14%
2. Acute-Phase Reaction 11%
3. Antigen-Antibody Complex 11%
4. Antinuclear Antibodies 17%
5. Antiphospholipid Antibodies 11%
6. Antiphospholipid Syndrome 12%
7. Autoantibodies 27%
8. Blood Sedimentation 11%
9. Cimetidine 10%
10. Collagen Type II 10%
11. Collagen Type III 10%
12. Common Variable Immunodeficiency 12%
13. Complementarity Determining Regions 20%
14. Cytokines 37%
15. DNA 22%
16. edratide 18%
17. Erythema Nodosum 12%
18. Familial erythema nodosum 21%
19. Frail Elderly 13%
20. Geriatrics 18%
21. Haplotypes 13%
22. Helper-Inducer T-Lymphocytes 12%
23. Hemiplegia 10%
24. HLA-B27 Antigen 11%
25. Hydroxychloroquine 11%
26. Immunization 15%
27. Immunogenetics 11%
28. In Vitro Techniques 10%
29. Interleukin-1 24%
30. Interleukin-10 10%
31. Interleukin-2 10%
32. Jews 24%
33. Leucovorin 10%
34. Methotrexate 85%
35. Minocycline 11%
36. Monoclonal Antibodies 18%
37. Oral Administration 15%
38. Peptides 13%
39. Pharmaceutical Preparations 11%
40. Pharmacokinetics 17%
41. Psoriatic Arthritis 10%
42. Regulatory T-Lymphocytes 10%
43. Rheumatoid Arthritis 80%
44. Roxithromycin 13%
45. Severe Combined Immunodeficiency 11%
46. Sjogren's Syndrome 20%
47. Sulfasalazine 11%
48. Systemic Lupus Erythematosus 100%
49. T-Lymphocytes 14%
50. Th2 Cells 10%